Skip to main navigation Skip to search Skip to main content

TP2001-201: A Randomized, Double-blind, Placebo-controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination with Erlotinib in Non-Small Cell Lung Cancer Patients (the Protocol)

Stony Brook University

Project: Research

Project Details

StatusFinished
Effective start/end date09/15/08 → 09/10/12

Funding

  • Tragara Pharmaceuticals Incorporated: $35,787.58